Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in pediatric plaque psoriasis (6-11 years)
NCT02698475Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 3 trial of ustekinumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started May 2016; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02698475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698475.